Alerts will be sent to your verified email
Verify EmailSHUKRAPHAR
|
Shukra Pharmaceut.
|
Amrutanjan Health.
|
Jagsonpal Pharma
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
14.12 % | 14.67 % | 16.01 % |
|
5yr average Equity Multiplier
|
2.02 | 1.41 | 1.27 |
|
5yr Average Asset Turnover Ratio
|
0.6 | 1.22 | 1.09 |
|
5yr Avg Net Profit Margin
|
13.41 % | 8.57 % | 12.08 % |
|
Price to Book
|
16.17 | 4.15 | 5.65 |
|
P/E
|
65.9 | 26.52 | 36.2 |
|
5yr Avg Cash Conversion Cycle
|
-114.74 Days | 21.59 Days | 2.39 Days |
|
Inventory Days
|
40.87 Days | 23.18 Days | 31.56 Days |
|
Days Receivable
|
186.38 Days | 51.48 Days | 15.63 Days |
|
Days Payable
|
342.97 Days | 49.13 Days | 59.94 Days |
|
5yr Average Interest Coverage Ratio
|
23.9 | 27.21 | 66.99 |
|
5yr Avg ROCE
|
14.63 % | 24.07 % | 18.99 % |
|
5yr Avg Operating Profit Margin
|
20.24 % | 14.15 % | 13.23 % |
|
5 yr average Debt to Equity
|
0.23 | 0.12 | 0.01 |
|
5yr CAGR Net Profit
|
119.04 % | 16.38 % | 26.54 % |
|
5yr Average Return on Assets
|
8.68 % | 10.59 % | 12.71 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
50.96 % | 46.52 % | 67.89 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
0.06 % | -3.52 % | -0.82 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.1 % | 0.0 |
|
Shukra Pharmaceut.
|
Amrutanjan Health.
|
Jagsonpal Pharma
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|